How We Work With Clinicians
Patients are best served when the all members of the provider team work together and are fully informed.
We value your expertise and welcome the opportunity to support you and your patients.
We Work With:
- Psychiatrists
- Therapists
- Psychologists
- Neurologists
- Pain Specialists
- Primary Care Physicians
- Coaches
- Social Workers
Our Services:
- IV Ketamine
- IV NAD+
- IV Nutrients & Vitamins
- Intranasal Ketamine & NAD+
- IV Glutathione
- Ketamine Assisted Psychotherapy (KAP)
Treatments for:
- Depression
- Anxiety
- PTSD
- Migraines & Headaches
- CRPS & Chronic Pain
- Immunity & Resilience
Clinicians
Emotional Pain
- Primary Care Physicians
- Neurologists
- Psychiatrists
- Psychologists
- Therapists/Counselors
- Life Coaches
- Social Workers
Physical Pain
- Pain Specialists
- Primary Care Physicians
- Surgeons
- Orthopedic Specialists
- Neurologists
- Physical Therapists
Healthspan
- Primary Care Physicians
- Functional Medicine Providers
- Dieticians
- Athletic Coaches
- Life Coaches
As soon as we receive your patient referral we will reach out to your patient via phone call. The purpose of this call is to confirm their interest in Combination Infusion Therapy and answer any questions they may have. If at the end of the call they would like to proceed they will be asked to submit a New Patient Intake Form. This provides us with the necessary contact information and medical history so we can begin onboarding them. After reviewing their intake information we will reach out to you to discuss your patient’s medical condition and better understand your reason for making the referral to CIT Clinics. If we still agree that these treatments may benefit your patient our team will begin scheduling their first treatment.
We pride ourselves in being very administratively efficient because it means we can intake new patients quickly and easily. Assuming there are no medical contraindications we can usually offer an appointment for new patients within 1 week of processing their intake form and speaking with you as their referring provider. Please begin your referral by submitting a New Patient Referral. If you have any questions about our process please call 415.475.9660. We’re happy to help.
Latest Science & Research
Trial of Psilocybin versus Escitalopram for Depression
Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking.
Read More
Comparative Efficacy of Racemic Ketamine and Esketamine for Depression
Intravenous ketamine appears to be more efficacious than intranasal esketamine for the treatment of depression.
Read More
Antidepressant Actions of Ketamine Engage Cell-Specific Translation via eIF4E
Sub-anaesthetic doses of ketamine, a noncompetitive N-methyl-d-aspartate receptor antagonist provide rapid and long-lasting antidepressant effects in these patients, but the molecular mechanism of these effects remains unclear.
Read More
Ketamine Can Reduce Harmful Drinking by “Rewriting” Your Memories
Maladaptive reward memories (MRMs) are involved in the development and maintenance of acquired overconsumption disorders, such as harmful alcohol and drug use. Here we demonstrate that the N-methyl D-aspartate (NMDA) antagonist ketamine is able to disrupt MRMs in hazardous drinkers when administered immediately after their retrieval.
Read More